Mimedx (MDXG) Cash from Investing Activities (2011 - 2026)
Mimedx's (MDXG) quarterly Cash from Investing Activities came in at -$635000.0 in Q2 2026, up 28.41% year-over-year from -$494508.3 in Q2 2025, and up 88.75% quarter-over-quarter from -$5.6 million in Q1 2026.
Powered by 
Analysis
Mimedx (MDXG) Cash from Investing Activities (2011 - 2026) Analysis & Trends
Mimedx has disclosed Cash from Investing Activities across 16 years of filings, most recently posting -$635000.0 for Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 28.41% year-over-year to -$635000.0; the TTM figure through Jun 2026 stood at -$11.9 million (down 200.73% YoY), while the FY2025 annual figure was -$6.9 million, up 28.14% from the prior year.
- Cash from Investing Activities came in at -$635000.0 for Q2 2026 at Mimedx, up from -$5.6 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $113000.0 in Q3 2024 to a low of -$6.0 million in Q1 2024.
- Average Cash from Investing Activities over 5 years is -$1.5 million, with a median of -$642000.0 recorded in 2023.
- Year-over-year, Cash from Investing Activities surged 117.41% in 2024 and slumped 4753.1% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$1.7 million in 2022, then soared by 71.85% to -$481000.0 in 2023, then plunged by 475.26% to -$2.8 million in 2024, then soared by 87.89% to -$335000.0 in 2025, then tumbled by 89.55% to -$635000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$635000.0 in Q2 2026, -$5.6 million in Q1 2026, and -$335000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 127.56 Bn | 122.34 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 103.85 Bn | 100.37 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 63.70 Bn | 63.16 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.88 Bn | 45.63 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 20.65 Bn | 20.17 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Mimedx | 670.99 Mn | 535.15 Mn | 44.38 Mn | -635,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -635,000.00 |
| Mar 31, 2026 | -5.64 Mn |
| Dec 31, 2025 | -335,000.00 |
| Sep 30, 2025 | -5.26 Mn |
| Jun 30, 2025 | -887,000.00 |
| Mar 31, 2025 | -406,000.00 |
| Dec 31, 2024 | -2.77 Mn |
| Sep 30, 2024 | 113,000.00 |
| Jun 30, 2024 | -905,000.00 |
| Mar 31, 2024 | -6.02 Mn |
| Dec 31, 2023 | -481,000.00 |
| Sep 30, 2023 | -649,000.00 |
| Jun 30, 2023 | -348,000.00 |
| Mar 31, 2023 | -677,000.00 |
| Dec 31, 2022 | -1.71 Mn |
| Sep 30, 2022 | -374,000.00 |
| Jun 30, 2022 | -429,000.00 |
| Mar 31, 2022 | -148,000.00 |
| Dec 31, 2021 | -314,000.00 |
| Sep 30, 2021 | -580,000.00 |